Eagle Pharmaceuticals
EGRX
#10469
Rank
A$5.82 M
Marketcap
A$0.45
Share price
36.36%
Change (1 day)
-51.52%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: A$5.82 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of A$5.82 Million. This makes Eagle Pharmaceuticals the world's 10469th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025A$5.82 M-49.14%
2024A$11.45 M-88.51%
2023A$99.69 M-82.17%
2022A$0.55 B-38.36%
2021A$0.90 B14.93%
2020A$0.78 B-32.53%
2019A$1.16 B46.98%
2018A$0.79 B-22.06%
2017A$1.02 B-40.06%
2016A$1.70 B-10.5%
2015A$1.90 B615.91%
2014A$0.26 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
A$5.82 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$748.79 B 12,848,753.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$147.50 B 2,530,930.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
A$393.70 B 6,755,584.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
A$53.67 B 920,979.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
A$267.51 B 4,590,217.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.446 T 24,823,713.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$166.81 B 2,862,284.01%๐Ÿ‡บ๐Ÿ‡ธ USA